teva pharmaceuticals usa, incdrugHigh PriorityActive

Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsipp

teva pharmaceuticals usa, inc Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsipp recalled by FDA. Subpotent drug; Clavulanate Potassium component

By RecallRadar Editorial Team

Sourced from FDA. Last reviewed March 4, 2026.

This recall involves safety concerns. Take action promptly.

✨ Plain-English Summary

Is This Recall Still Active?

Status: Yes - Active

This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source: FDA
Announced by source: October 13, 2025
Last reviewed by RecallRadar: March 4, 2026

What You Should Do

1## Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsipp Agency: FDA | Category: drug Reason: Subpotent drug; Clavulanate Potassium component What to do:
2Stop using the product if your lot/model matches.
3Check the FDA notice for specifics.
4Follow remedy instructions.

Open Official Recall Notice Get Alerts for teva pharmaceuticals usa, inc Devices

What's Being Recalled

Quoted source excerpt from the official notice.

Subpotent drug; Clavulanate Potassium component

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot # 100062316, Exp Date: 01/2026

#	Model
1	Lot # 100062316, Exp Date: 01/2026

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

Frequently Asked Questions

Is my teva pharmaceuticals usa, inc device affected?

Check the affected models section on this page. The official notice currently lists Lot # 100062316, Exp Date: 01/2026.

What is the remedy for this recall?

## Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsipp Agency: FDA | Category: drug Reason: Subpotent drug; Clavulanate Potassium component What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: teva pharmaceuticals usa, inc recall hub and Food & Drug recall hub.